Literature DB >> 2824382

Antigenic structure of Clostridium botulinum type B neurotoxin and its interaction with gangliosides, cerebroside, and free fatty acids.

S Kozaki1, J Ogasawara, Y Shimote, Y Kamata, G Sakaguchi.   

Abstract

A fragment distinct from the heavy and light chains was obtained by treatment of Clostridium botulinum type B neurotoxin with chymotrypsin. Enzyme-linked immunosorbent assay and immunoblotting analysis with monoclonal antibodies showed that the fragment consisted of the light chain and part of the heavy chain (H-1 fragment) linked together by a disulfide bond. Monoclonal antibodies reacting to the heavy chain but not to the fragment were thought to recognize the epitopes on the remaining portion (H-2 fragment) of the heavy chain, being easily digested by chymotrypsin. Thus, the antigenic structure of type B neurotoxin resembles those of type A and E neurotoxins. The chymotrypsin-induced fragment bound to cerebroside and free fatty acids but not to gangliosides. The manner of binding of type B neurotoxin to gangliosides and free fatty acids was different from those of type A and E neurotoxins. Such differences in the reactivities to lipids may be related to the finding that each neurotoxin binds to a type-specific site on the neural membrane.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824382      PMCID: PMC260027          DOI: 10.1128/iai.55.12.3051-3056.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Ganglioside inactivation of botulinum toxin.

Authors:  L L Simpson; M M Rapport
Journal:  J Neurochem       Date:  1971-07       Impact factor: 5.372

4.  Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.

Authors:  S Kozaki; S Miyazaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  A common subunit structure in Clostridium botulinum type A, B and E toxins.

Authors:  B R DasGupta; H Sugiyama
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

6.  Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments.

Authors:  T B Helting; O Zwisler
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

7.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

8.  Interaction of botulinum type A, B and E derivative toxins with synaptosomes of rat brain.

Authors:  S Kozaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-07       Impact factor: 3.000

9.  The isolation of IgG from mammalian sera with the aid of caprylic acid.

Authors:  M Steinbuch; R Audran
Journal:  Arch Biochem Biophys       Date:  1969-11       Impact factor: 4.013

10.  Interaction between Clostridium botulinum neurotoxin and gangliosides.

Authors:  M Kitamura; M Iwamori; Y Nagai
Journal:  Biochim Biophys Acta       Date:  1980-03-20
View more
  7 in total

1.  Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes.

Authors:  S Kozaki; A Miki; Y Kamata; J Ogasawara; G Sakaguchi
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin.

Authors:  S Kozaki; J Onimaru; Y Kamata; G Sakaguchi
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

3.  Sequence homology between tetanus and botulinum toxins detected by an antipeptide antibody.

Authors:  J L Halpern; L A Smith; K B Seamon; K A Groover; W H Habig
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan.

Authors:  S Kozaki; Y Kamata; T Nishiki; H Kakinuma; H Maruyama; H Takahashi; T Karasawa; K Yamakawa; S Nakamura
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

5.  Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; J K Brehm; T Atkinson; N P Minton
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

Review 6.  Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.

Authors:  Laura M Zarebski; Kerrie Vaughan; John Sidney; Bjoern Peters; Howard Grey; Kim D Janda; Arturo Casadevall; Alessandro Sette
Journal:  Expert Rev Vaccines       Date:  2008-02       Impact factor: 5.217

7.  Retargeted clostridial neurotoxins as novel agents for treating chronic diseases.

Authors:  Felix L Yeh; Yiming Zhu; William H Tepp; Eric A Johnson; Paul J Bertics; Edwin R Chapman
Journal:  Biochemistry       Date:  2011-11-07       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.